The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2025
Synopsis
The global Topical Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs include Roche, Viatris, Teva Pharmaceutical Industries, Sanofi, Pfizer, GlaxoSmithKline, Novartis, Zydus Cadila, Boehringer Ingelheim International, Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Topical Non-Steroidal Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Non-Steroidal Anti-Inflammatory Drugs.
The Topical Non-Steroidal Anti-Inflammatory Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Topical Non-Steroidal Anti-Inflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topical Non-Steroidal Anti-Inflammatory Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Viatris
Teva Pharmaceutical Industries
Sanofi
Pfizer
GlaxoSmithKline
Novartis
Zydus Cadila
Boehringer Ingelheim International
Apotex
AstraZeneca
Horizon Therapeutics
Johnson & Johnson
Bayer
Perrigo Company
Tolmar Pharmaceuticals
Sun Pharmaceutical Industries
Assertio Therapeutics
Daiichi Sankyo
Segment by Type
Gel
Cream
Liquid Spray
Paste
Other
Segment by Application
Skin Inflammation
Arthritis
Sprains
Everyday Injuries
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Topical Non-Steroidal Anti-Inflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Topical Non-Steroidal Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Topical Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs include Roche, Viatris, Teva Pharmaceutical Industries, Sanofi, Pfizer, GlaxoSmithKline, Novartis, Zydus Cadila, Boehringer Ingelheim International, Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Topical Non-Steroidal Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Non-Steroidal Anti-Inflammatory Drugs.
The Topical Non-Steroidal Anti-Inflammatory Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Topical Non-Steroidal Anti-Inflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topical Non-Steroidal Anti-Inflammatory Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Viatris
Teva Pharmaceutical Industries
Sanofi
Pfizer
GlaxoSmithKline
Novartis
Zydus Cadila
Boehringer Ingelheim International
Apotex
AstraZeneca
Horizon Therapeutics
Johnson & Johnson
Bayer
Perrigo Company
Tolmar Pharmaceuticals
Sun Pharmaceutical Industries
Assertio Therapeutics
Daiichi Sankyo
Segment by Type
Gel
Cream
Liquid Spray
Paste
Other
Segment by Application
Skin Inflammation
Arthritis
Sprains
Everyday Injuries
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Topical Non-Steroidal Anti-Inflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Topical Non-Steroidal Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Topical Non-Steroidal Anti-Inflammatory Drugs Market Overview
1.1 Product Definition
1.2 Topical Non-Steroidal Anti-Inflammatory Drugs by Type
1.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Gel
1.2.3 Cream
1.2.4 Liquid Spray
1.2.5 Paste
1.2.6 Other
1.3 Topical Non-Steroidal Anti-Inflammatory Drugs by Application
1.3.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Value by Application (2024-2030)
1.3.2 Skin Inflammation
1.3.3 Arthritis
1.3.4 Sprains
1.3.5 Everyday Injuries
1.3.6 Other
1.4 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Size Estimates and Forecasts
1.4.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2030
1.4.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2030
1.4.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Topical Non-Steroidal Anti-Inflammatory Drugs Market Competition by Manufacturers
2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Topical Non-Steroidal Anti-Inflammatory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs, Product Type & Application
2.7 Global Key Manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
2.8 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Competitive Situation and Trends
2.8.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Topical Non-Steroidal Anti-Inflammatory Drugs Players Market Share by Revenue
2.8.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Scenario by Region
3.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2019-2030
3.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2019-2024
3.2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2025-2030
3.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2019-2030
3.3.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2019-2024
3.3.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2025-2030
3.4 North America Topical Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.4.1 North America Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.4.3 North America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.5.1 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.5.3 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.7.1 Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.7.3 Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2030)
4.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
4.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2025-2030)
4.1.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2030)
4.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2019-2030)
4.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2019-2024)
4.2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2025-2030)
4.2.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2030)
5.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
5.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2025-2030)
5.1.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2030)
5.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2019-2030)
5.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2019-2024)
5.2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2025-2030)
5.2.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Company Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Teva Pharmaceutical Industries
6.3.1 Teva Pharmaceutical Industries Company Information
6.3.2 Teva Pharmaceutical Industries Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Company Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Zydus Cadila
6.8.1 Zydus Cadila Company Information
6.8.2 Zydus Cadila Description and Business Overview
6.8.3 Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.8.5 Zydus Cadila Recent Developments/Updates
6.9 Boehringer Ingelheim International
6.9.1 Boehringer Ingelheim International Company Information
6.9.2 Boehringer Ingelheim International Description and Business Overview
6.9.3 Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.9.5 Boehringer Ingelheim International Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Company Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Company Information
6.11.2 AstraZeneca Description and Business Overview
6.11.3 AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 Horizon Therapeutics
6.12.1 Horizon Therapeutics Company Information
6.12.2 Horizon Therapeutics Description and Business Overview
6.12.3 Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.12.5 Horizon Therapeutics Recent Developments/Updates
6.13 Johnson & Johnson
6.13.1 Johnson & Johnson Company Information
6.13.2 Johnson & Johnson Description and Business Overview
6.13.3 Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.13.5 Johnson & Johnson Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Company Information
6.14.2 Bayer Description and Business Overview
6.14.3 Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 Perrigo Company
6.15.1 Perrigo Company Company Information
6.15.2 Perrigo Company Description and Business Overview
6.15.3 Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.15.5 Perrigo Company Recent Developments/Updates
6.16 Tolmar Pharmaceuticals
6.16.1 Tolmar Pharmaceuticals Company Information
6.16.2 Tolmar Pharmaceuticals Description and Business Overview
6.16.3 Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.16.5 Tolmar Pharmaceuticals Recent Developments/Updates
6.17 Sun Pharmaceutical Industries
6.17.1 Sun Pharmaceutical Industries Company Information
6.17.2 Sun Pharmaceutical Industries Description and Business Overview
6.17.3 Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.17.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.18 Assertio Therapeutics
6.18.1 Assertio Therapeutics Company Information
6.18.2 Assertio Therapeutics Description and Business Overview
6.18.3 Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.18.5 Assertio Therapeutics Recent Developments/Updates
6.19 Daiichi Sankyo
6.19.1 Daiichi Sankyo Company Information
6.19.2 Daiichi Sankyo Description and Business Overview
6.19.3 Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.19.5 Daiichi Sankyo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Topical Non-Steroidal Anti-Inflammatory Drugs Industry Chain Analysis
7.2 Topical Non-Steroidal Anti-Inflammatory Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Topical Non-Steroidal Anti-Inflammatory Drugs Production Mode & Process
7.4 Topical Non-Steroidal Anti-Inflammatory Drugs Sales and Marketing
7.4.1 Topical Non-Steroidal Anti-Inflammatory Drugs Sales Channels
7.4.2 Topical Non-Steroidal Anti-Inflammatory Drugs Distributors
7.5 Topical Non-Steroidal Anti-Inflammatory Drugs Customers
8 Topical Non-Steroidal Anti-Inflammatory Drugs Market Dynamics
8.1 Topical Non-Steroidal Anti-Inflammatory Drugs Industry Trends
8.2 Topical Non-Steroidal Anti-Inflammatory Drugs Market Drivers
8.3 Topical Non-Steroidal Anti-Inflammatory Drugs Market Challenges
8.4 Topical Non-Steroidal Anti-Inflammatory Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Topical Non-Steroidal Anti-Inflammatory Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Topical Non-Steroidal Anti-Inflammatory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Topical Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Topical Non-Steroidal Anti-Inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Non-Steroidal Anti-Inflammatory Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Topical Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Topical Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Topical Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Topical Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Viatris Company Information
Table 76. Viatris Description and Business Overview
Table 77. Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 79. Viatris Recent Developments/Updates
Table 80. Teva Pharmaceutical Industries Company Information
Table 81. Teva Pharmaceutical Industries Description and Business Overview
Table 82. Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 84. Teva Pharmaceutical Industries Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 94. Pfizer Recent Developments/Updates
Table 95. GlaxoSmithKline Company Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 104. Novartis Recent Developments/Updates
Table 105. Zydus Cadila Company Information
Table 106. Zydus Cadila Description and Business Overview
Table 107. Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 109. Zydus Cadila Recent Developments/Updates
Table 110. Boehringer Ingelheim International Company Information
Table 111. Boehringer Ingelheim International Description and Business Overview
Table 112. Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 114. Boehringer Ingelheim International Recent Developments/Updates
Table 115. Apotex Company Information
Table 116. Apotex Description and Business Overview
Table 117. Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 119. Apotex Recent Developments/Updates
Table 120. AstraZeneca Company Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 124. AstraZeneca Recent Developments/Updates
Table 125. Horizon Therapeutics Company Information
Table 126. Horizon Therapeutics Description and Business Overview
Table 127. Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 129. Horizon Therapeutics Recent Developments/Updates
Table 130. Johnson & Johnson Company Information
Table 131. Johnson & Johnson Description and Business Overview
Table 132. Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 134. Johnson & Johnson Recent Developments/Updates
Table 135. Bayer Company Information
Table 136. Bayer Description and Business Overview
Table 137. Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 139. Bayer Recent Developments/Updates
Table 140. Perrigo Company Company Information
Table 141. Perrigo Company Description and Business Overview
Table 142. Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 144. Perrigo Company Recent Developments/Updates
Table 145. Tolmar Pharmaceuticals Company Information
Table 146. Tolmar Pharmaceuticals Description and Business Overview
Table 147. Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 149. Tolmar Pharmaceuticals Recent Developments/Updates
Table 150. Sun Pharmaceutical Industries Company Information
Table 151. Sun Pharmaceutical Industries Description and Business Overview
Table 152. Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 154. Sun Pharmaceutical Industries Recent Developments/Updates
Table 155. Assertio Therapeutics Company Information
Table 156. Assertio Therapeutics Description and Business Overview
Table 157. Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 159. Assertio Therapeutics Recent Developments/Updates
Table 160. Daiichi Sankyo Company Information
Table 161. Daiichi Sankyo Description and Business Overview
Table 162. Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Product
Table 164. Daiichi Sankyo Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Topical Non-Steroidal Anti-Inflammatory Drugs Distributors List
Table 168. Topical Non-Steroidal Anti-Inflammatory Drugs Customers List
Table 169. Topical Non-Steroidal Anti-Inflammatory Drugs Market Trends
Table 170. Topical Non-Steroidal Anti-Inflammatory Drugs Market Drivers
Table 171. Topical Non-Steroidal Anti-Inflammatory Drugs Market Challenges
Table 172. Topical Non-Steroidal Anti-Inflammatory Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Topical Non-Steroidal Anti-Inflammatory Drugs
Figure 2. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Share by Type: 2023 & 2030
Figure 4. Gel Product Picture
Figure 5. Cream Product Picture
Figure 6. Liquid Spray Product Picture
Figure 7. Paste Product Picture
Figure 8. Other Product Picture
Figure 9. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Share by Application: 2023 & 2030
Figure 11. Skin Inflammation
Figure 12. Arthritis
Figure 13. Sprains
Figure 14. Everyday Injuries
Figure 15. Other
Figure 16. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Size (2019-2030) & (US$ Million)
Figure 18. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales (2019-2030) & (K Units)
Figure 19. Global Topical Non-Steroidal Anti-Inflammatory Drugs Average Price (US$/Unit) & (2019-2030)
Figure 20. Topical Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
Figure 21. Topical Non-Steroidal Anti-Inflammatory Drugs Sales Share by Manufacturers in 2023
Figure 22. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers in 2023
Figure 23. Global 5 and 10 Largest Topical Non-Steroidal Anti-Inflammatory Drugs Players: Market Share by Revenue in Topical Non-Steroidal Anti-Inflammatory Drugs in 2023
Figure 24. Topical Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
Figure 27. North America Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2030)
Figure 28. United States Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
Figure 31. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2030)
Figure 32. Germany Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2019-2030)
Figure 39. China Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
Figure 47. Mexico Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
Figure 52. Middle East and Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Topical Non-Steroidal Anti-Inflammatory Drugs by Type (2019-2030)
Figure 57. Global Revenue Market Share of Topical Non-Steroidal Anti-Inflammatory Drugs by Type (2019-2030)
Figure 58. Global Topical Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Topical Non-Steroidal Anti-Inflammatory Drugs by Application (2019-2030)
Figure 60. Global Revenue Market Share of Topical Non-Steroidal Anti-Inflammatory Drugs by Application (2019-2030)
Figure 61. Global Topical Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2019-2030)
Figure 62. Topical Non-Steroidal Anti-Inflammatory Drugs Value Chain
Figure 63. Topical Non-Steroidal Anti-Inflammatory Drugs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
